MCRB icon

Seres Therapeutics

77 hedge funds and large institutions have $258M invested in Seres Therapeutics in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 34 increasing their positions, 17 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

15% less funds holding

Funds holding: 9177 (-14)

64% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 22

Holders
77
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.23M
Puts
$160K
Net Calls
Net Calls Change

Top Sellers

1 -$8.05M
2 -$3.82M
3 -$3.13M
4
Goldman Sachs
Goldman Sachs
New York
-$2.06M
5
Marshall Wace
Marshall Wace
United Kingdom
-$1.53M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$86.5M
2
$30.7M
3
$30.7M
4
$28.7M
5
$28.4M
6
$16M
7
$8.39M
8
$4.33M
9
$2.37M
10
$2.3M
11
$2.2M
12
$1.91M
13
$1.66M
14
$1.53M
15
$1.43M
16
$1.03M
17
$942K
18
$786K
19
$630K
20
$612K
21
$473K
22
$459K
23
$395K
24
$385K
25
$370K